Literature DB >> 31452080

Non-invasive Brain Stimulation for Alcohol Use Disorders: State of the Art and Future Directions.

Noah S Philip1,2, David O Sorensen3, Daniel M McCalley4, Colleen A Hanlon4.   

Abstract

Alcohol use disorders remain one of the leading causes of mortality and morbidity across the world, yet despite this impact, there are few treatment options for patients suffering from these disorders. To this end, non-invasive brain stimulation, most commonly utilizing technologies including transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS), has recently emerged as promising potential treatments for alcohol use disorders. Enthusiasm for these interventions is fueled by their non-invasive nature, generally favorable safety profile, and ability to target and modulate brain regions implicated in substance use disorders. In this paper, we describe the underlying principles behind these commonly used stimulation technologies, summarize existing experiments and randomized controlled trials, and provide an integrative summary with suggestions for future areas of research. Currently available data generally supports the use of non-invasive brain stimulation as a near-term treatment for alcohol use disorder, with important caveats regarding the use of stimulation in this patient population.

Entities:  

Keywords:  Transcranial magnetic stimulation; alcohol use disorders; neural architecture; non-invasive brain stimulation; transcranial direct current stimulation

Mesh:

Year:  2020        PMID: 31452080      PMCID: PMC7007491          DOI: 10.1007/s13311-019-00780-x

Source DB:  PubMed          Journal:  Neurotherapeutics        ISSN: 1878-7479            Impact factor:   7.620


  15 in total

1.  Field modeling for transcranial magnetic stimulation: A useful tool to understand the physiological effects of TMS?

Authors:  Axel Thielscher; Andre Antunes; Guilherme B Saturnino
Journal:  Conf Proc IEEE Eng Med Biol Soc       Date:  2015

2.  Alcohol and suicidality: could deep transcranial magnetic stimulation (dTMS) be a possible treatment?

Authors:  Chiara Rapinesi; Georgios D Kotzalidis; Paola Scatena; Antonio Del Casale; Delfina Janiri; Gemma Callovini; Daria Piacentino; Daniele Serata; Ruggero N Raccah; Roberto Brugnoli; Vittorio Digiacomantonio; Flavia Mascioli; Vittoria Rachele Ferri; Stefano Ferracuti; Maurizio Pompili; Eleonora De Pisa; Simone Di Pietro; Abraham Zangen; Gloria Angeletti; Paolo Girardi
Journal:  Psychiatr Danub       Date:  2014-09       Impact factor: 1.063

3.  [Rheumatology in general practice].

Authors:  V Rejholec
Journal:  Vnitr Lek       Date:  1974-02

4.  [Nature of clinical nursing. 5].

Authors:  K Hirose
Journal:  Sogo Kango       Date:  1972

5.  The effect of age upon the lipids of the long bones of the rat.

Authors:  T Sakai; R L Cruess; K Iida
Journal:  Proc Soc Exp Biol Med       Date:  1969-10

6.  The true disease pattern in East Africa. Part 1.

Authors:  E M Nordberg
Journal:  East Afr Med J       Date:  1983-07

7.  [Malignant pleural mesothelioma: clinical aspects and results of treatment].

Authors:  P Leblanc; M Desmeules
Journal:  Union Med Can       Date:  1984-11

8.  Comparison of ultrasonically nebulized distilled water and hyperventilation with cold air in asthma.

Authors:  L M Fabbri; C E Mapp; D J Hendrick
Journal:  Ann Allergy       Date:  1984-08

9.  [Electrograms of the abomasum in the case of dyspepsia in calves].

Authors:  B M Anokhin; A N Trusov
Journal:  Veterinariia       Date:  1965-12

10.  [Cylindroma of the base of the skull with longstanding neurological disturbances. Anatomo-clinical correlation].

Authors:  M Depierreux; J Brihaye; J Gybels; J Flament-Durand
Journal:  Acta Neurol Belg       Date:  1980 Jan-Feb       Impact factor: 2.396

View more
  8 in total

1.  The neurobiological markers of acute alcohol's subjective effects in humans.

Authors:  Raphael Hamel; Olivier Demers; Camille Boileau; Marie-Laurence Roy; Hugo Théoret; Pierre-Michel Bernier; Jean-Francois Lepage
Journal:  Neuropsychopharmacology       Date:  2022-06-14       Impact factor: 8.294

2.  Compulsive alcohol drinking in rodents is associated with altered representations of behavioral control and seeking in dorsal medial prefrontal cortex.

Authors:  Nicholas M Timme; Baofeng Ma; David Linsenbardt; Ethan Cornwell; Taylor Galbari; Christopher C Lapish
Journal:  Nat Commun       Date:  2022-07-09       Impact factor: 17.694

3.  Prefrontal cortex parvalbumin interneurons exhibit decreased excitability and potentiated synaptic strength after ethanol reward learning.

Authors:  Anthony S Ferranti; Kari A Johnson; Danny G Winder; P Jeffrey Conn; Max E Joffe
Journal:  Alcohol       Date:  2022-02-26       Impact factor: 2.558

4.  Regionally specific gray matter volume is lower in alcohol use disorder: Implications for noninvasive brain stimulation treatment.

Authors:  Daniel M McCalley; Colleen A Hanlon
Journal:  Alcohol Clin Exp Res       Date:  2021-08-02       Impact factor: 3.928

5.  Neurofilament Light Chain as a Biomarker for Monitoring the Efficacy of Transcranial Magnetic Stimulation on Alcohol Use Disorder.

Authors:  Tian Zhang; Bin Song; Yanfei Li; Ranran Duan; Zhe Gong; Lijun Jing; Kaixin Wang; Bingquan Ma; Yanjie Jia
Journal:  Front Behav Neurosci       Date:  2022-02-07       Impact factor: 3.558

Review 6.  Targeting prefrontal cortex GABAergic microcircuits for the treatment of alcohol use disorder.

Authors:  Kenneth N Fish; Max E Joffe
Journal:  Front Synaptic Neurosci       Date:  2022-08-29

7.  Intermittent Theta Burst Stimulation in Veterans with Mild Alcohol Use Disorder.

Authors:  Melanie L Bozzay; Sydney Brigido; Mascha van 't Wout-Frank; Emily Aiken; Robert Swift; Noah S Philip
Journal:  J Affect Disord       Date:  2021-06-24       Impact factor: 6.533

Review 8.  Repetitive transcranial magnetic stimulation as a potential treatment approach for cannabis use disorder.

Authors:  Tonisha Kearney-Ramos; Margaret Haney
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2021-03-04       Impact factor: 5.201

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.